Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Ginsenoside Rg3-enriched red ginseng extract inhibits platelet activation and in vivo thrombus formation

  • Jeong, Dahye (Department of Veterinary Medicine, College of Veterinary Medicine, Kyungpook National University) ;
  • Irfan, Muhammad (Department of Veterinary Medicine, College of Veterinary Medicine, Kyungpook National University) ;
  • Kim, Sung-Dae (Research Center, Dongnam Institute of Radiological and Medical Sciences) ;
  • Kim, Suk (College of Veterinary Medicine, Gyeongsang National University) ;
  • Oh, Jun-Hwan (Research and Development Headquarters, Korean Ginseng Corporation) ;
  • Park, Chae-Kyu (Research and Development Headquarters, Korean Ginseng Corporation) ;
  • Kim, Hyun-Kyoung (Department of Veterinary Medicine, College of Veterinary Medicine, Kyungpook National University) ;
  • Rhee, Man Hee (Department of Veterinary Medicine, College of Veterinary Medicine, Kyungpook National University)
  • Received : 2016.11.01
  • Accepted : 2016.11.28
  • Published : 2017.10.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Korean Red Ginseng has been used for several decades to treat many diseases, enhancing both immunity and physical strength. Previous studies have documented the therapeutic effects of ginseng, including its anticancer, antiaging, and anti-inflammatory activities. These activities are mediated by ginsenosides present in the ginseng plant. Ginsenoside Rg3, an effective compound from red ginseng, has been shown to have antiplatelet activity in addition to its anticancer and anti-inflammatory activities. Platelets are important for both primary hemostasis and the repair of the vessels after injury; however, they also play a crucial role in the development of acute coronary diseases. We prepared ginsenoside Rg3-enriched red ginseng extract (Rg3-RGE) to examine its role in platelet physiology. Methods: To examine the effect of Rg3-RGE on platelet activation in vitro, platelet aggregation, granule secretion, intracellular calcium ($[Ca^{2+}]_i$) mobilization, flow cytometry, and immunoblot analysis were carried out using rat platelets. To examine the effect of Rg3-RGE on platelet activation in vivo, a collagen plus epinephrine-induced acute pulmonary thromboembolism mouse model was used. Results: We found that Rg3-RGE significantly inhibited collagen-induced platelet aggregation and $[Ca^{2+}]_i$ mobilization in a dose-dependent manner in addition to reducing ATP release from collagen-stimulated platelets. Furthermore, using immunoblot analysis, we found that Rg3-RGE markedly suppressed mitogen-activated protein kinase phosphorylation (i.e., extracellular stimuli-responsive kinase, Jun N-terminal kinase, p38) as well as the PI3K (phosphatidylinositol 3 kinase)/Akt pathway. Moreover, Rg3-RGE effectively reduced collagen plus epinephrine-induced mortality in mice. Conclusion: These data suggest that ginsenoside Rg3-RGE could be potentially be used as an antiplatelet therapeutic agent against platelet-mediated cardiovascular disorders.

Keywords

References

  1. Ghoshal K, Bhattacharyya M. Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis. Sci World J 2014;2014:781857.
  2. Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007;357:2482-94. https://doi.org/10.1056/NEJMra071014
  3. Grozovsky R, Giannini S, Falet H, Hoffmeister KM. Regulating billions of blood platelets: glycans and beyond. Blood 2015;126:1877-84. https://doi.org/10.1182/blood-2015-01-569129
  4. Bye AP, Unsworth AJ, Gibbins JM. Platelet signaling: a complex interplay between inhibitory and activatory networks. J Thromb Haemost 2016;14:918-30. https://doi.org/10.1111/jth.13302
  5. Barrett NE, Holbrook L, Jones S, Kaiser WJ, Moraes LA, Rana R, Sage T, Stanley RG, Tucker KL, Wright B, et al. Future innovations in anti-platelet therapies. Br J Pharmacol 2008;154:918-39. https://doi.org/10.1038/bjp.2008.151
  6. Lee SM, Bae BS, Park HW, Ahn NG, Cho BG, Cho YL, Kwak YS. Characterization of Korean Red Ginseng (Panax ginseng Meyer): history, preparation method, and chemical composition. J Ginseng Res 2015;39:384-91. https://doi.org/10.1016/j.jgr.2015.04.009
  7. Kim KS, Jung Yang H, Lee IS, Kim KH, Park J, Jeong HS, Kim Y, Ahn KS, Na YC, Jang HJ. The aglycone of ginsenoside Rg3 enables glucagon-like peptide-1 secretion in enteroendocrine cells and alleviates hyperglycemia in type 2 diabetic mice. Sci Rep 2015;5:18325.
  8. Lee KH, Bae IY, Park SI, Park JD, Lee HG. Antihypertensive effect of Korean Red Ginseng by enrichment of ginsenoside Rg3 and arginine-fructose. J Ginseng Res 2016;40:237-44. https://doi.org/10.1016/j.jgr.2015.08.002
  9. Zhang Y, Liu QZ, Xing SP, Zhang JL. Inhibiting effect of Endostar combined with ginsenoside Rg3 on breast cancer tumor growth in tumor-bearing mice. Asian Pac J Trop Med 2016;9:180-3. https://doi.org/10.1016/j.apjtm.2016.01.010
  10. Liu T, Peng YF, Jia C, Yang BH, Tao X, Li J, Fang X. Ginsenoside Rg3 improves erectile function in streptozotocin-induced diabetic rats. J Sex Med 2015;12:611-20. https://doi.org/10.1111/jsm.12779
  11. Lee WM, Kim SD, Park MH, Cho JY, Park HJ, Seo GS, Rhee MH. Inhibitory mechanisms of dihydroginsenoside Rg3 in platelet aggregation: critical roles of ERK2 and cAMP. J Pharm Pharmacol 2008;60:1531-6. https://doi.org/10.1211/jpp.60.11.0015
  12. Endale M, Lee WM, Kamruzzaman SM, Kim SD, Park JY, Park MH, Park TY, Park HJ, Cho JY, Rhee MH. Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation. Br J Pharmacol 2012;167:109-27. https://doi.org/10.1111/j.1476-5381.2012.01967.x
  13. Bye AP, Unsworth AJ, Vaiyapuri S, Stainer AR, Fry MJ, Gibbins JM. Ibrutinib inhibits platelet integrin alphaIIbbeta3 outside-in signaling and thrombus stability but not adhesion to collagen. Arterioscler Thromb Vasc Biol 2015;35:2326-35. https://doi.org/10.1161/ATVBAHA.115.306130
  14. Canobbio I, Cipolla L, Consonni A, Momi S, Guidetti G, Oliviero B, Falasca M, Okigaki M, Balduini C, Gresele P, Torti M. Impaired thrombin-induced platelet activation and thrombus formation in mice lacking the Ca(2+)-dependent tyrosine kinase Pyk2. Blood 2013;121:648-57. https://doi.org/10.1182/blood-2012-06-438762
  15. Shattil SJ, Newman PJ. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood 2004;104:1606-15. https://doi.org/10.1182/blood-2004-04-1257
  16. Oury C, Toth-Zsamboki E, Vermylen J, Hoylaerts MF. P2X(1)-mediated activation of extracellular signal-regulated kinase 2 contributes to platelet secretion and aggregation induced by collagen. Blood 2002;100:2499-505. https://doi.org/10.1182/blood-2002-03-0812
  17. Arslan R, Bor Z, Bektas N, Mericli AH, Ozturk Y. Antithrombotic effects of ethanol extract of Crataegus orientalis in the carrageenan-induced mice tail thrombosis model. Thromb Res 2011;127:210-3. https://doi.org/10.1016/j.thromres.2010.11.028
  18. Li Z, Delaney MK, O'Brien KA, Du X. Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol 2010;30:2341-9. https://doi.org/10.1161/ATVBAHA.110.207522
  19. Chuang WY, Kung PH, Kuo CY, Wu CC. Sulforaphane prevents human platelet aggregation through inhibiting the phosphatidylinositol 3-kinase/Akt pathway. Thromb Haemost 2013;109:1120-30. https://doi.org/10.1160/TH12-09-0636
  20. Michelson AD. Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov 2010;9:154-69. https://doi.org/10.1038/nrd2957
  21. Sharma G, Berger JS. Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the data. J Thromb Thrombolysis 2011;32:201-8. https://doi.org/10.1007/s11239-011-0590-9
  22. Stegner D, Dutting S, Nieswandt B. Mechanistic explanation for platelet contribution to cancer metastasis. Thromb Res 2014;133(Suppl 2):S149-57. https://doi.org/10.1016/S0049-3848(14)50025-4
  23. Kakudo N, Morimoto N, Kushida S, Ogawa T, Kusumoto K. Platelet-rich plasma releasate promotes angiogenesis in vitro and in vivo. Med Mol Morphol 2014;47:83-9. https://doi.org/10.1007/s00795-013-0045-9
  24. Thomas MR, Storey RF. The role of platelets in inflammation. Thromb Haemost 2015;114:449-58. https://doi.org/10.1160/TH14-12-1067
  25. Byeon SE, Lee J, Kim JH, Yang WS, Kwak YS, Kim SY, Choung ES, Rhee MH, Cho JY. Molecular mechanism of macrophage activation by red ginseng acidic polysaccharide from Korean red ginseng. Mediators Inflamm 2012;2012:732860.
  26. Li H, Kang T, Qi B, Kong L, Jiao Y, Cao Y, Zhang J, Yang J. Neuroprotective effects of ginseng protein on PI3K/Akt signaling pathway in the hippocampus of d-galactose/AlCl3 inducing rats model of Alzheimer's disease. J Ethnopharmacol 2016;179:162-9. https://doi.org/10.1016/j.jep.2015.12.020
  27. Kim S, Lee Y, Cho J. Korean red ginseng extract exhibits neuroprotective effects through inhibition of apoptotic cell death. Biol Pharm Bull 2014;37:938-46. https://doi.org/10.1248/bpb.b13-00880
  28. Joo SS, Won TJ, Lee DI. Reciprocal activity of ginsenosides in the production of proinflammatory repertoire, and their potential roles in neuroprotection in vivo. Planta Med 2005;71:476-81. https://doi.org/10.1055/s-2005-864145
  29. Baeg IH, So SH. The world ginseng market and the ginseng (Korea). J Ginseng Res 2013;37:1-7. https://doi.org/10.5142/jgr.2013.37.1
  30. Annie-Jeyachristy S, Geetha A, Surendran R. Changes in the level of cytosolic calcium, nitric oxide and nitric oxide synthase activity during platelet aggregation: an in vitro study in platelets from normal subjects and those with cirrhosis. J Biosci 2008;33:45-53. https://doi.org/10.1007/s12038-008-0020-0
  31. Cimmino G, Golino P. Platelet biology and receptor pathways. J Cardiovasc Transl Res 2013;6:299-309. https://doi.org/10.1007/s12265-012-9445-9
  32. Guidetti GF, Canobbio I, Torti M. PI3K/Akt in platelet integrin signaling and implications in thrombosis. Adv Biol Regul 2015;59:36-52. https://doi.org/10.1016/j.jbior.2015.06.001
  33. Jackson SP, Schoenwaelder SM, Goncalves I, Nesbitt WS, Yap CL, Wright CE, Kenche V, Anderson KE, Dopheide SM, Yuan Y, et al. PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med 2005;11:507-14. https://doi.org/10.1038/nm1232
  34. Adam F, Kauskot A, Rosa JP, Bryckaert M. Mitogen-activated protein kinases in hemostasis and thrombosis. J Thromb Haemost 2008;6:2007-16. https://doi.org/10.1111/j.1538-7836.2008.03169.x
  35. Haeusgen W, Herdegen T, Waetzig V. The bottleneck of JNK signaling: molecular and functional characteristics of MKK4 and MKK7. Eur J Cell Biol 2011;90:536-44. https://doi.org/10.1016/j.ejcb.2010.11.008
  36. Angelillo-Scherrer A, de Frutos P, Aparicio C, Melis E, Savi P, Lupu F, Arnout J, Dewerchin M, Hoylaerts M, Herbert J, et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001;7:215-21. https://doi.org/10.1038/84667

Cited by

  1. Inhibitory Effects of Total Saponin Korean Red Ginseng on Thromboxane A2 Production and P-Selectin Expression via Suppressing Mitogen-Activated Protein Kinases vol.23, pp.4, 2017, https://doi.org/10.15616/bsl.2017.23.4.310
  2. Astilbe chinensis Modulates Platelet Function via Impaired MAPK and PLC γ 2 Expression vol.2018, pp.None, 2017, https://doi.org/10.1155/2018/3835021
  3. Anti-Inflammatory Activity of Rg3-Enriched Korean Red Ginseng Extract in Murine Model of Sepsis vol.2018, pp.None, 2018, https://doi.org/10.1155/2018/6874692
  4. The Multivariate Regression Statistics Strategy to Investigate Content-Effect Correlation of Multiple Components in Traditional Chinese Medicine Based on a Partial Least Squares Method vol.23, pp.3, 2017, https://doi.org/10.3390/molecules23030545
  5. Identification of certain Panax species to be potential substitutes for Panax notoginseng in hemostatic treatments vol.134, pp.None, 2017, https://doi.org/10.1016/j.phrs.2018.05.005
  6. 20(S)-ginsenoside Rg3 inhibits glycoprotein IIb/IIIa activation in human platelets vol.61, pp.3, 2017, https://doi.org/10.3839/jabc.2018.037
  7. Antiplatelet Effects of Garlic and Chitosan: a Comparative Study between Fermented and Non-Fermented Preparations vol.24, pp.3, 2017, https://doi.org/10.15616/bsl.2018.24.3.280
  8. A comparative study of the antithrombotic effect through activated endothelium of garlic powder and tomato extracts using a rodent model of collagen and epinephrine induced thrombosis vol.27, pp.5, 2018, https://doi.org/10.1007/s10068-018-0469-z
  9. Inhibitory Effect of 20(S)-Ginsenoside Rg3 on Human Platelet Aggregation and Intracellular Ca 2+ Levels via Cyclic Adenosine Monophosphate Dependent Manner vol.23, pp.4, 2018, https://doi.org/10.3746/pnf.2018.23.4.317
  10. The Effects of Environmental Factors on Ginsenoside Biosynthetic Enzyme Gene Expression and Saponin Abundance vol.24, pp.1, 2017, https://doi.org/10.3390/molecules24010014
  11. Fermented Garlic Ameliorates Hypercholesterolemia and Inhibits Platelet Activation vol.2019, pp.None, 2017, https://doi.org/10.1155/2019/3030967
  12. A Review of Antiplatelet Activity of Traditional Medicinal Herbs on Integrative Medicine Studies vol.2019, pp.None, 2019, https://doi.org/10.1155/2019/7125162
  13. Effects of coffee, energy drinks and their components on hemostasis: The hypothetical mechanisms of their action vol.127, pp.None, 2017, https://doi.org/10.1016/j.fct.2019.02.039
  14. Production of Rare Ginsenosides Rg3 and Rh2 by Endophytic Bacteria from Panax ginseng vol.67, pp.31, 2017, https://doi.org/10.1021/acs.jafc.9b03159
  15. Antihypertensive Effects of Rg3-Enriched Korean Vitamin Ginseng in Spontaneously Hypertensive Rats vol.15, pp.1, 2017, https://doi.org/10.1177/1934578x19900712
  16. Insights into gastrointestinal microbiota-generated ginsenoside metabolites and their bioactivities vol.52, pp.1, 2020, https://doi.org/10.1080/03602532.2020.1714645
  17. Platelet Protease Activated Receptor 1 Is Involved in the Hemostatic Effect of 20( S )-Protopanaxadiol by Regulating Calcium Signaling vol.11, pp.None, 2017, https://doi.org/10.3389/fphar.2020.549150
  18. Cooperated biotransformation of ginsenoside extracts into ginsenoside 20(S)‐Rg3 by three thermostable glycosidases vol.128, pp.3, 2020, https://doi.org/10.1111/jam.14513
  19. 반응표면분석을 이용한 진생베리의 활성 성분 최적 추출 조건에 관한 연구 vol.46, pp.2, 2017, https://doi.org/10.15230/scsk.2020.46.2.185
  20. Adaptogenic effects of Panax ginseng on modulation of cardiovascular functions vol.44, pp.4, 2017, https://doi.org/10.1016/j.jgr.2020.03.001
  21. The effects of ginsenosides on platelet aggregation and vascular intima in the treatment of cardiovascular diseases: From molecular mechanisms to clinical applications vol.159, pp.None, 2020, https://doi.org/10.1016/j.phrs.2020.105031
  22. 상업용 β-glucanase를 이용한 홍삼유래 사포닌으로부터 Ginsnoside Rd 의 생물 전환 vol.46, pp.4, 2017, https://doi.org/10.15230/scsk.2020.46.4.349
  23. Effects of Ginsenoside Rg3 on Inhibiting Differentiation, Adipogenesis, and ER Stress-Mediated Cell Death in Brown Adipocytes vol.2021, pp.None, 2017, https://doi.org/10.1155/2021/6668665
  24. Bioactive Foods and Medicinal Plants for Cardiovascular Complications of Type II Diabetes: Current Clinical Evidence and Future Perspectives vol.2021, pp.None, 2017, https://doi.org/10.1155/2021/6681540
  25. Evaluation of Metabolite Profiles of Ginseng Berry Pomace Obtained after Different Pressure Treatments and Their Correlation with the Antioxidant Activity vol.26, pp.2, 2021, https://doi.org/10.3390/molecules26020284
  26. Ginsenosides for cardiovascular diseases; update on pre-clinical and clinical evidence, pharmacological effects and the mechanisms of action vol.166, pp.None, 2021, https://doi.org/10.1016/j.phrs.2021.105481
  27. Ginsenoside Rg3 Attenuates Early Hepatic Injury via Inhibiting PPARγ- and Ang II-Related Inflammation and Fibrosis in Type II Diabetic Mice vol.16, pp.4, 2017, https://doi.org/10.1177/1934578x211009691
  28. Ginsenosides in vascular remodeling: Cellular and molecular mechanisms of their therapeutic action vol.169, pp.None, 2021, https://doi.org/10.1016/j.phrs.2021.105647
  29. Ginsenoside Rg3 inhibits pulmonary fibrosis by preventing HIF-1α nuclear localisation vol.21, pp.1, 2021, https://doi.org/10.1186/s12890-021-01426-5
  30. P2Y12 antagonists: Approved drugs, potential naturally isolated and synthesised compounds, and related in-silico studies vol.227, pp.None, 2017, https://doi.org/10.1016/j.ejmech.2021.113924